From Ferroptosis to Immune Control with IL-2
2026-09-18
Carbon-ion radiotherapy may do more than damage gastric cancer cells: emerging evidence links it to DHODH suppression, ferroptosis, and M1-like macrophage polarization. This article translates that mechanistic signal into a practical validation strategy and positions IL-2, human recombinant as a controlled variable for testing whether radiation-shaped immune environments can be made functionally productive.
Recombinant Human IL-6 in Blastoid Assays
2026-09-18
Recombinant Human IL-6, Tag Free provides a controlled cytokine perturbation for exploring how inflammatory signaling may intersect with WDR36-dependent glycolysis and trophectoderm differentiation in human blastoid models.
JXY, TLR4, and M1 Polarization in CAC
2026-09-17
Liu et al. show that Jiedu Xiaozheng Yin suppresses colitis-associated colorectal cancer in mice while shifting intestinal macrophages toward an M1-like phenotype through TLR4-associated signaling. The study combines an orthotopic disease model with histology, immunohistochemistry, macrophage functional assays, and pharmacologic pathway perturbation to connect immune polarization with tumor progression.
Rhamnolipid-Stabilized mRNA Nanovaccines
2026-09-17
The reference study develops PEG-free lipid nanoparticles in which microbial rhamnolipids provide both colloidal stabilization and intrinsic immune stimulation. Its experiments associate rhamnolipid-containing particles with dendritic-cell targeting, lymph-node-biased expression, stronger Th1 and cytotoxic T-cell responses, and reduced mast-cell infiltration during repeat dosing.
BODIPY 581/591 C11: Reliable Lipid Peroxidation
2026-09-16
Learn how BODIPY 581/591 C11 (SKU C8003) supports ratiometric lipid peroxidation detection, oxidative stress measurement, and comparative antioxidant capacity evaluation in live-cell and membrane workflows. This scenario-based guide covers assay design, spectral interpretation, protocol optimization, and practical vendor selection.
RNA Pol II Inhibition and Active Apoptotic Signaling
2026-09-16
Harper and colleagues show that RNA polymerase II inhibition kills cells through an actively regulated apoptotic response rather than through passive loss of transcription, mRNA, or protein. Their functional-genomic and rescue experiments identify loss of hypophosphorylated RNA Pol IIA as the initiating signal and define a Pol II degradation-dependent apoptotic response with implications for cancer biology and drug-mechanism interpretation.
VX-765 for Caspase-1 and Pyroptosis Studies
2026-09-15
VX-765 provides a selective way to connect caspase-1 activity with IL-1β and IL-18 release, pyroptotic death, and inflammatory phenotypes. This practical workflow shows how to apply it in endothelial, macrophage, autoimmune, and infectious-disease models while separating pathway-specific effects from general cytotoxicity.
VX-765 Workflow for Caspase-1 Inflammation Studies
2026-09-15
VX-765 enables selective interrogation of caspase-1-dependent cytokine release, pyroptosis, and barrier injury across biochemical, cellular, and preclinical workflows. This guide translates the compound’s prodrug biology into practical assay design, with troubleshooting guidance for macrophage, blood-brain barrier, rheumatoid arthritis, and infectious-disease studies.
Radicicol: A Mechanistic Assay Guide
2026-09-14
Radicicol is an Hsp90 inhibitor with a broader experimental profile spanning adipocyte differentiation, apoptosis, kinase ATP-site biology, and inflammation. This guide shows how to use the compound as a mechanistic perturbation tool while distinguishing its validated actions from the non-canonical thermogenesis findings reported for hyperforin.
HIV-1 Protease Autoprocessing for HTS
2026-09-14
Huang et al. developed a cell-based AlphaLISA assay that measures HIV-1 protease precursor autoprocessing rather than only mature protease activity. The validated platform detected known HIV protease inhibitor activity, reproduced resistance-associated effects, and provides a selective framework for high-throughput discovery and drug-resistance assessment.
BmTyr Click Labeling Maps Primary T-Cell Proteomes
2026-09-13
The reference study introduces a copper-dependent BmTyr proximity-labeling platform that uses an alkyne-phenol probe and azide-bearing tags instead of biotin. In primary T cells, the approach supports subcellular proteome profiling, antibody-independent validation, and discovery of a chromatin-associated localization for NKAP.
Bradykinin (BA5201): Practical Assay Guide
2026-09-12
Bradykinin (BA5201) provides a defined research reagent for acute studies of endothelium-dependent vasodilation, vascular permeability modulation, smooth muscle contraction, and inflammation-related responses. It is intended for controlled laboratory workflows, not diagnostic, clinical, or long-term solution use.
Zolmitriptan: From Receptor Selectivity to Assays
2026-09-11
Zolmitriptan is a versatile 5-HT1B receptor agonist for mechanistic migraine and cluster headache research. This guide presents a distinct, evidence-aware framework for connecting receptor identity, temporal assay design, compound handling, and translational interpretation without overextending lysosomal antiviral findings.
α-Amanitin: From Transcription to Toxicity
2026-09-11
α-Amanitin is more than a selective RNA polymerase II inhibitor: it can connect transcriptional perturbation with oxidative-stress biology. This guide explains how to design, interpret, and control α-amanitin experiments across cell, embryo, and hepatotoxicity models.
Diminazene Aceturate: A Two-Axis Research Framework
2026-09-10
Diminazene Aceturate can support both trypanosome parasite research and pharmacological ACE2 activation research, but these applications require different controls and interpretations. This article presents an evidence-based framework for separating direct antiparasitic activity from host mitochondrial biogenesis findings.